1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. California >
  6. Insulet Acquires Automated Glucose Control

M&A Deal Summary

Insulet Acquires Automated Glucose Control

On February 14, 2023, Insulet acquired information technology company Automated Glucose Control

Acquisition Highlights
  • This is Insulet’s 1st transaction in the Information Technology sector.
  • This is Insulet’s 2nd transaction in the United States.
  • This is Insulet’s 2nd transaction in California.

M&A Deal Summary
Date 2023-02-14
Target Automated Glucose Control
Sector Information Technology
Buyer(s) Insulet
Deal Type Add-on Acquisition

Target

Automated Glucose Control

Palo Alto, California, United States
Automated Glucose Control is focused on developing and commercializing automated insulin delivery technology. Automated Glucose Control is based in Palo Alto, California.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Insulet

Acton, Massachusetts, United States
Category Company
Founded 2000
Sector Medical Products
Employees3,900
Revenue 2.1B USD (2024)
DESCRIPTION

Insulet is a medical device company, which develops and manufactures insulin infusion systems for people with insulin-dependent diabetes. Insulet was founded in 2000 and is based in Acton, Massachusetts.

DEAL STATS #
Overall 2 of 2
Sector: Information Technology M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: California M&A 2 of 2
Country: United States M&A 2 of 2
Year: 2023 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-02-13 Bigfoot Biomedical - Insulin Pump Patents

Milpitas, California, United States

Bigfoot Biomedical's Insulin Pump Patents provides automated insulin delivery (AID) technologies.

Buy $25M
Mergr

Solution for

Product

Company

Legal